How to make pharma manufacturing more energy efficient
And why it really matters.
Global volatility in energy markets looks set to continue for some time. This means organizations in all industries need to make energy efficiency their primary concern. But it is of the utmost importance for energy-intensive sectors with low margins, such as metallurgy, pulp and paper, and fertilizers. In some cases, companies in these sectors have been forced to cease operations. If the pharmaceutical manufacturing, which is considered an energy-intensive space, is going to thrive throughout this period of volatility, it needs to get serious about how it sources, stores, and uses energy. This is because just a 15-20% increase in energy bills would lead to higher medicine prices and disruption to production. So, what’s the next step?
One of the main levers pharma companies can use is data and digital. The information generated by Capgemini Invent’s technological systems can improve energy performance management. Our holistic approach to energy uses data and digital solutions to target renewable sources, energy reduction plans, and infrastructural improvements. Our new Life Sciences PoV expands on this, highlighting the transformative potential of our technological systems. We can help pharma companies control, optimize, and modify their operational framework for quick wins and long-term growth. Moreover, we bring pharma companies up to speed with market movements and outline strategies to harness the advantages of energy efficiency. Our reduce, reuse, and maintain or replace methodology can return the power to pharmaceuticals.
Download for free: